Држава: Ирска
Језик: Енглески
Извор: HPRA (Health Products Regulatory Authority)
DILTIAZEM HYDROCHLORIDE
LTT Pharma Limited
DILTIAZEM HYDROCHLORIDE
300 Milligram
Prolonged Release Capsules
Product subject to prescription which may be renewed (B)
Authorised
0000-00-00
TILDIEM LA 300MG PROLONGED-RELEASE HARD CAPSULES (diltiazem hydrochloride) PATIENT INFORMATION LEAFLET READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. * Keep this leaflet. You may need to read it again. * If you have any further questions, ask your doctor or pharmacist. * This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours * If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. Your medicine is called Tildiem LA 300mg Prolonged-Release Hard Capsules but will be referred to as Tildiem LA throughout the leaflet. IN THIS LEAFLET: What Tildiem LA is and what it is used for Before you take Tildiem LA How to take Tildiem LA Possible side effects How to store Tildiem LA Further information WHAT TILDIEM LA IS AND WHAT IT IS USED FOR Tildiem LA contains a medicine called diltiazem hydrochloride. This belongs to a group of medicines called ‘calcium-channel blockers’. It works by making your blood vessels wider. This helps to lower your blood pressure. It also makes it easier for your heart to pump blood around the body. This helps to prevent the chest pain caused by angina. Tildiem LA is used for: * High blood pressure * Angina (chest pain) BEFORE YOU TAKE TILDIEM LA DO NOT TAKE THIS MEDICINE AND TELL YOUR DOCTOR IF: * You are allergic (hypersensitive) to diltiazem hydrochloride or any of the other ingredients of Tildiem LA (listed in Section 6 below) Signs of an allergic reaction include: a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue. * You are having a medicine called dantrolene used for severe muscle spasms or severe fever (see Section below: ‘Taking other medicines’). * You have a very slow heartbeat - less than 40 beats per minute. * You have heart failure and problems with blood flow to your lungs. With these illnesses, yo Прочитајте комплетан документ
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Tildiem LA 300 mg Prolonged-Release Hard Capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 300 mg diltiazem hydrochloride as the active ingredient in a combination of immediate-release and coated prolonged-release pellets. For full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Prolonged-release, hard capsules. _Product imported from Greece_ Opaque capsules with a white body and a yellow cap. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS As a calcium antagonist for use in the management of angina pectoris and mild to moderate hypertension. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Dosage and administration: Tildiem LA 200 and Tildiem LA 300 are sustained release products for once daily dosing. The capsules should not be crushed or chewed but swallowed whole with water, ideally before or during a meal. The dosage requirements may differ in patients with angina or hypertension. Tildiem (diltiazem hydrochloride) is available in a range of presentations to enable dosage to be adjusted to meet the individual requirements of the patient. Careful titration of the dose should be considered where appropriate, as individual patient response may vary. When changing from one type of Tildiem formulation to another, it may be necessary to adjust the dosage until a satisfactory response is obtained. To ensure consistency of response once established, particularly in the sustained release formulations, Tildiem LA 200 and Tildiem LA 300 should continue to be prescribed by brand name. Tildiem LA 300 has been used following an acute myocardial infarction initially treated with thrombolysis, in the absence of congestive heart failure (see section 5.1 Pharmacodynamics). Adults: Angina and hype Прочитајте комплетан документ